Company / Current Assets
Opus Genetics, Inc. Current Assets History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$50.0M
FY2025
5-year range
$26.1M / $53.9M
FY2021-FY2025
Trend
+36.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $54M to $50M over the past 2 years.
Based on SEC 10-K filings.
$50M in FY2025 with a 3-year CAGR of +0.7%.
Declined from $54M to $50M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +0.7%, indicating consistent growth.
- In FY2025, current assets increased 36.7% year-over-year.
- Peak current assets was recorded in FY2023.
- Lowest current assets in the period was in FY2011.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $50.0M | +36.7% |
| FY2024 | $36.6M | -32.1% |
| FY2023 | $53.9M | +10.1% |
| FY2022 | $49.0M | +87.9% |
| FY2021 | $26.1M | +35.1% |
| FY2013 | $19.3M | +58.6% |
| FY2011 | $12.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026